The document summarizes the results of a respondent driven sampling study on initiation into injecting drug use among young IDUs and their non-IDU peers in Ukraine. The study found that most participants' first injection involved a home-produced opiate taken in a group of friends at the apartment of a friend. The injection was usually administered by a close friend or, for women, a sexual partner, and obtained from a close friend for free. Initiation was generally unplanned. The study proposed peer-based interventions targeting both IDUs and non-IDUs to establish norms discouraging initiation and promoting safer drug use.
Knowledge, Attitude and Practice of Unintentional Injuries Among Old People i...Scientific Review SR
Objective: To describe the KAP (knowledge, attitude and practice, KAP) and explore the influence factors for UIs (unintentional injuries, UIs) among the elderly (aged>﹦60 years) in urban districts of Zunyi, China. Methods: Using random cluster sampling method, a survey was conducted with questionnaires, to collect UIs and related KAP in the elderly and analyze its influencing factors. Results: The annual incidence of UIs (falls, burns, traffics, etc.) was 17.46% in some urban districts of Zunyi. Among them, 27.94% elderly regarded UI as a type of disease; the channels to acquire related knowledge through TV (79.05%), listening to others’ narration (56.83%), community publicity (26.03%), books or newspapers (22.86%) and internet (9.84%). While 76.51% of the elderly believed that UIs were preventable; 81.59% old people worried about UIs; 93.97% of the elderly chose to seek help when they suffered UIs; and 95.25% of elderly people followed traffic rules when crossing the road. In the case of gas use, 25.77% of the cases were checked and closed each time, 40% and 20% old people would check the time before taking the medicine, and purchasing food. Factors affecting the occurrence of UIs were age, heart disease (both P<0.05). Moreover, the living condition had an effect on “whether considering UIs as a kind of disease” (P=0.003). Conclusion: The KAP of UIs in the elderly is not optimistic, though most elderly people think the damage can be prevented; prevention on UIs related behavior needs to be enhanced. We should arouse the public to pay more attentions to keep elderly people far away UIs risk factors in this area.
Knowledge, Attitude and Practice of Unintentional Injuries Among Old People i...Scientific Review SR
Objective: To describe the KAP (knowledge, attitude and practice, KAP) and explore the influence factors for UIs (unintentional injuries, UIs) among the elderly (aged>﹦60 years) in urban districts of Zunyi, China. Methods: Using random cluster sampling method, a survey was conducted with questionnaires, to collect UIs and related KAP in the elderly and analyze its influencing factors. Results: The annual incidence of UIs (falls, burns, traffics, etc.) was 17.46% in some urban districts of Zunyi. Among them, 27.94% elderly regarded UI as a type of disease; the channels to acquire related knowledge through TV (79.05%), listening to others’ narration (56.83%), community publicity (26.03%), books or newspapers (22.86%) and internet (9.84%). While 76.51% of the elderly believed that UIs were preventable; 81.59% old people worried about UIs; 93.97% of the elderly chose to seek help when they suffered UIs; and 95.25% of elderly people followed traffic rules when crossing the road. In the case of gas use, 25.77% of the cases were checked and closed each time, 40% and 20% old people would check the time before taking the medicine, and purchasing food. Factors affecting the occurrence of UIs were age, heart disease (both P<0.05). Moreover, the living condition had an effect on “whether considering UIs as a kind of disease” (P=0.003). Conclusion: The KAP of UIs in the elderly is not optimistic, though most elderly people think the damage can be prevented; prevention on UIs related behavior needs to be enhanced. We should arouse the public to pay more attentions to keep elderly people far away UIs risk factors in this area.
Material para los temas de violencia familiar, contra niños, mayores de familia, mujeres en la familia, factores de riesgo y factores protectores asociados a la violencia familiar, identificacion prevencion y control de la violencia familiar y servicios de apoyo
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...SACAP
Harm Reduction acknowledges that drug use occurs and is potentially damaging, and attempts
to reduce and prevent these harms in ways, which are pragmatic and humanistic. Although the
harm reduction approach and specific harm reduction interventions (including needle and
syringe programmed and methadone programmed) have been implemented with resounding
success internationally (including in a number of African countries) for more than 20 years, the
South African approach to substance use and substance-related harms is still largely informed
by the doctrine and strategies of the "War on Drugs", and focuses almost exclusively on
prohibition and punishment. Because of the strong link between drug use and poverty, different
policy approaches to poverty and homelessness must also be considered. My talk will critically
examine these two approaches to drug use, poverty, and displacement (support or punish), as
they are being implemented in Cape Town. Opportunity for discussion will be provided.
Join us as we discuss best practices for integrating HIV prevention (e.g. HIV testing, PrEP and linkage to care) into primary care within the context of enhancing clinical workforce development.
Panelists:
• Marwan Haddad, MD, MPH, AAHIVS, Medical Director, Center for Key Populations, Community Health Center, Inc.
• Jeannie McIntosh, APRN, FNP-C, AAHIVS, Family Nurse Practitioner, Center for Key Populations, Community Health Center, Inc.
Drug use patterns among participants in a woman-focused RCT in GeorgiaIrma Kirtadze M.D.
The purpose of this poster presentation is to depict preliminary results from small-scale RCT IMEDI study and show the drug use patterns among women who use illicit substance and the rate of HIV infection.
Risk and stigma in seeking care and policy implicationsIrma Kirtadze M.D.
The study is assessing the development of an efficacious comprehensive women-centered drug treatment model. This presentation demonstrates results from qualitative research.
Material para los temas de violencia familiar, contra niños, mayores de familia, mujeres en la familia, factores de riesgo y factores protectores asociados a la violencia familiar, identificacion prevencion y control de la violencia familiar y servicios de apoyo
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...SACAP
Harm Reduction acknowledges that drug use occurs and is potentially damaging, and attempts
to reduce and prevent these harms in ways, which are pragmatic and humanistic. Although the
harm reduction approach and specific harm reduction interventions (including needle and
syringe programmed and methadone programmed) have been implemented with resounding
success internationally (including in a number of African countries) for more than 20 years, the
South African approach to substance use and substance-related harms is still largely informed
by the doctrine and strategies of the "War on Drugs", and focuses almost exclusively on
prohibition and punishment. Because of the strong link between drug use and poverty, different
policy approaches to poverty and homelessness must also be considered. My talk will critically
examine these two approaches to drug use, poverty, and displacement (support or punish), as
they are being implemented in Cape Town. Opportunity for discussion will be provided.
Join us as we discuss best practices for integrating HIV prevention (e.g. HIV testing, PrEP and linkage to care) into primary care within the context of enhancing clinical workforce development.
Panelists:
• Marwan Haddad, MD, MPH, AAHIVS, Medical Director, Center for Key Populations, Community Health Center, Inc.
• Jeannie McIntosh, APRN, FNP-C, AAHIVS, Family Nurse Practitioner, Center for Key Populations, Community Health Center, Inc.
Drug use patterns among participants in a woman-focused RCT in GeorgiaIrma Kirtadze M.D.
The purpose of this poster presentation is to depict preliminary results from small-scale RCT IMEDI study and show the drug use patterns among women who use illicit substance and the rate of HIV infection.
Risk and stigma in seeking care and policy implicationsIrma Kirtadze M.D.
The study is assessing the development of an efficacious comprehensive women-centered drug treatment model. This presentation demonstrates results from qualitative research.
This presentation was given by Annie Madden, Executive Officer, Australian Injecting & Illicit Drug Users League (AIVL), at the AFAO Members Forum – May 2015.
Diffusion of Drug Trends, NPS, the Internet and Consequences for EpidemiologyJean-Paul Grund
In this presentation I consider the changes in markets for illicit and 'unscheduled' drugs related to the ever growing influence of technology in the last 20 years.
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...Jean-Paul Grund
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A Square Peg in a Round Hole?
This lecture will discuss a number of challenges and problems in Randomized Controlled Trials (RCTs), in particular in evaluating interventions aimed at (i) altering complex human behaviour, (ii) in marginalized and stigmatized populations; and, (iii) by socially complex interventions. Using examples from the literature and his own research, Dr. Grund will provide a transdisciplinary perspective on the utility of the RCT model in evaluating interventions aimed at, for example, people who use drugs or homeless people, two very complex “Real World” problems in the Czech Republic and elsewhere.
He argues that the arena of services for PUD, the homeless and other marginalised populations is rife with poorly understood contingencies. Consequently, the complexity of the research environment becomes a function of I, ii and iii above, but with enigmatic mathematical operators. Strategies for addressing this complexity through accompanying process evaluation and qualitative research will be discussed.
Dutch drug policy - coffee shops & compromise (2014)Jean-Paul Grund
Full text can be downloaded in English and Polish at: http://www.opensocietyfoundations.org/reports/coffee-shops-and-compromise-separated-illicit-drug-markets-netherlands
Though famous for its coffee shops, where cannabis can be purchased and consumed, the Netherlands has accomplished many enviable public health outcomes through its drug policy. These include low prevalence of HIV among people who use drugs, negligible incidence of heroin use, lower cannabis use among young people than in many stricter countries, and a citizenry that has generally been spared the burden of criminal records for low level, nonviolent drug offenses.
Coffee Shops and Compromise: Separated Illicit Drug Markets in the Netherlands tells the history of the Dutch approach and describes the ongoing success of the country’s drug policy. This includes the impact of the Dutch “separation of markets,” which potentially limits people’s exposure and access to harder drugs.
Though coffee shops have traditionally commanded the most media attention, the Netherlands also pioneered needle exchange and safer consumption rooms, decriminalized possession of small quantities of drugs, and introduced easy-to-access treatment services.
These policies, coupled with groundbreaking harm reduction interventions, have resulted in the near-disappearance of HIV among people who inject drugs and the lowest rate of problem drug use in Europe.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
1. Initiation Into Injecting Drug Use In Ukraine:
Results From a Respondent Driven Sampling
Study Among Young IDUs and Non-IDU Peers
Jean-Paul Grund, Olga Balakireva, Olena Sakovich,
Yuliya Rubanets, Marina Ryabova, Cas Barendregt,
Nataliya Levchuk, Tatyana Bondar
2. Project Data
• Project Title: Preventing Initiation of Injecting Drug Use
amongst Vulnerable Adolescents and Youth in Ukraine
• Implemented by:
- Ukrainian Institute for Social Research
(Olga Balakireva (PI), Yuliya Rubanets, Marina
Ryabova, Nataliya Levchuk, Tatyana Bondar);
- DV8 Research, Training & Development, Rotterdam,
the Netherlands (Jean-Paul Grund (co-PI));
- Addiction Research Institute (IVO) Rotterdam, the
Netherlands (Cas Barendregt)
4. BACKGROUND:
A TWIN EPIDEMIC OF IDU AND HIV (i)
• Registered drug users in Ukraine:
– 1990
43.2 per 100K pop.
– 2005
179.2 per 100K pop. (Ministry
of Health of Ukraine. 2006)
• Number of IDUs in Ukraine:
– 560.000 (Social Monitoring Center, 2002)
– 424.700 (consensus estimate of national
HIV/AIDS specialists, 2005)
5. BACKGROUND:
A TWIN EPIDEMIC OF IDU AND HIV (ii)
• Injecting drug use remains main mode of HIV
transmission:
– 2005: 45.5% of PLWHA infected through IDU
(Ukrainian AIDS Center, 2006)
BUT…
– Existing HIV testing and HIV case registration
system seriously underestimates actual
number of HIV-positive IDUs (UAC /UNAIDS, 2002)
– Local Sentinel Surveillance studies suggest HIV
prevalence among IDUs between 10% and 59%,
with IDUs aged 15 to 19 at highest risk.
– IDU population keeps growing in number
6. STUDY OBJECTIVES
• Present prevention approaches either tend to emphasize targeted
interventions aimed at established drug injectors or public
information campaigns, aiming at informing the general public in
a ‘broadcast’ fashion.
• Importance of needle exchange, Substitution treatment and other
harm reduction interventions, but…
• Is it possible to “Break the Cycle” of initiation into IDU?
– Little scientific information is available on the determinants of initiation
into injecting drug use among youth. From Ukraine and other post Soviet
countries none whatsoever.
Study aims:
• Provide data on the process of initiation into injecting drug use
• Serve as foundation for prevention activities seeking to reduce the
incidence & prevalence of IDU
7. Study Design
• Literature review on (prevention of) initiation of
injecting drug use among youth and support
services for young/novice injecting drug users
(IDUs);
• In-depth interviews with young/recent IDUs;
• Quantitative survey of young/recent IDUs
and their non-injecting friends in four cities
(Kyiv, Odesa, Poltava and Pavlograd);
• Each phase informed the following
8. Survey Methodology
• Respondent Driven Sampling (Heckathorn,
1997, 2002) in four cities:
Kyiv, Odesa, Poltava and Pavlohrad;
• Target Populations:
1. Injecting drug users (IDUs) up to 23 years of age,
having injected at least once in the last 3 months);
not in treatment for drug addiction and not involved
in rehabilitation programs at the time of interview.
2. IDUs’ friends who do not inject drugs (non-IDUs)
up to 23 years of age (thus including non-users
(NUs) and users of non-injected drugs (NIDUs))
9. IDU 1 recruits 4 freinds: 3 IDUs and 1 non-IDU
IDU 1
IDU 1.1
IDU 1.2
IDU 1.3
The same scheme as for IDU-1
IDU 1.1.1
IDU 1.1.2
Non-IDU
Non-IDU respondents do not
recruit!
Non-IDU
IDU 1.1.3
The same scheme as for IDU-1
IDU 20
IDU 20.1
IDU 20.2
IDU 20.3
Non-IDU
The same scheme as for IDU-1
Seeds: IDU 1 ...... IDU20
RDS
Recruitment
Scheme
10. The Resulting Sample
Non-injecting friends (non-IDUs),
N=802
Kyiv
Odesa
Pavlograd
Poltava
Kyiv
Odesa
Pavlograd
Poltava
Injecting drug users
(IDUs), N=808
25%
25%
25%
25%
25%
25%
25%
25%
205
201
199
203
199
201
Use drugs
non-injectingly
(NIDUs), N=476
200
201
Do not use any
illegal drugs (NU),
N=326
13. Drugs of first injection by city of
residence (% )
Among all IDUs
25
60
Pavlograd
5
55
35
0
Poltava
11
77
Odesa
2
12
68
Kyiv
9
23
59
0%
10
20%
Poppy straw extract
9
40%
60%
Amphtamines
80%
Heroin
10
11
11
9
100%
Others
14. Social Setting of the First Hit
“Who was present at your first injection?”*
Company
%
Friends or good acquaintances
80
Person I did not know very well
20
Sexual partner
17
Stranger
7
Alone
5
* More than one answer was possible.
15. Social Setting of the First Hit
“Who gave you the first injection?” by gender (%)
64
Friend, acquantance
55
67
13
Self-made
4
15
8
Sexual partner
32
3
6
Drug dealer
2
7
5
Running body
4
5
1
O ther persons
3
3
0
10
20
Men
30
40
Women
50
60
All
70
80
16. Social Setting of the First Hit
Average age of first injection:
17.7 years
Average age of “Initiator”:
22.8 years
Initiator is usually an IDU friend
First drug of injection is usually obtained from a close
friend, free of charge
Most common location of IDU initiation:
A friend‘s apartment
17. Behavioral risks associated with the first
injection (i)
• “At my initiation other people
used the same drug.”
• Obtained first drug injected
as liquid in syringe
• “Each in the group had
his/her own syringe”
80%
75%
21%
18. Behavioral risks associated with the first
injection (ii)
• didn’t know / unsure whether syringe
was used by someone before or not
33%
– Associated with Age: Younger at initiation increasing
incertainty;
– Associated with length of Non-IDU use:
2 Years
4 Years
32%
21%
• 50% was high on AOD
“At the time of my first injection I was under the influence of alcohol
and marijuana.” (Poltava, female, 19 years).
19. Behavioral risks associated with the first
injection (iii)
“Did you use a sterile needle during the first injection?"
by other drug use (%)
% 80
70
60
50
40
30
20
10
0
73
62
38
56
49
43
51
26
Had not used any stuff
Non-injecting drugs
Do not know/unsure whether the syringe was new
Alcohol
Alcohol and non-injecting
drugs
Sure, it was a new syringe
20. Behavioral risks associated with the first
injection (iv)
Other drug use during the first injection by gender (%)
% 60
50
55
44
38
Men
Women
40
25
30
14
20
11
5
10
6
0
Had not used any
stuff
Non-injecting drugs
Alcohol
Syringe sharing at the first injection: Men:
Women
Alcohol and noninjecting drugs
29%
51%
21. The reproduction of injecting drug use
• 167 IDUs (21%) initiated 605 Novice IDUs
Reproduction Rate: 3.6 per initiator or 0.7 for
whole sample
– Males:
22%, RR 3.83
– Females: 16%, RR 2.61
“Did you ever initiate a novice?”
%
Yes, I did
21
No. of times:
7
twice
6
tree or more
No, I didn’t
once
8
79
22. Initiation into IDU: Planned or Spontaneous?
Planning the first and the second injection, by gender (%)
100
% 90
80
70
60
50
40
30
20
10
0
100
%
90
80
70
60
50
60
44
40
30
20
10
First injection
Men
Second
injection
45
28
0
First injection
Women
Second
injection
23. Did you ever want to try an injecting drug?
(%) of the NIDUs and NUs
NIDUs
NUs
No, never
56
80
Yes, a couple of times
37
17
Yes, quite often
5
1
Yes, I really would like to try an injecting
drug
2
2
24. Self-Assessment of the probability of
initiating IDU among NIDUs and NUs (%)
5
Sure they will try one day
10
Not going to try injecting drugs so far, but don’t know
how the things will be going later on
30
34
65
Sure they will never try injecting drugs
56
0
NIDUs
10
20
30
40
50
60
70
NUs
80
90 100
25. First injection:
Summary
•
•
•
•
Mostly home-produced opiate;
Taken in a group of friends;
At the apartment of a friend;
Administered by a close friend or, in the case of
women, a sexual partner;
• Obtained from a close friend, free of charge;
• Generally an unplanned event.
Additional data on:
– Motivations for & Barriers to initiation of drug
injecting
– Risk & Protective Factors
26. Peer-based interventions targeting (young) IDUs,
Interventions targeting IDUs to prevent initiation of
other, that is:
- to not inject in the presence of non-injectors;
- to not give other people their first injection;
- inform non-injectors on the negative effects of
injecting drug use.
• XXXXX
IDUs
Non-IDUs
aiming at changes in sub-cultural norms towards
rejecting initiation of non-IDUs:
•Do not give other people (e.g. non-IDUs friends)
their first injection
•Do not inject in the presence of non-IDUs
•Honestly inform non-IDUs on the consequences of
injecting drug use (health, habit)
•Example: Break the Cycle (Hunt 1998)
Proposed
Strategy
Peer-based interventions targeting NIDUs & experimental IDUs, aiming at
Abstinence-based drug education:
establishing sub-cultural norms favoring non-injecting modes of administration:
interventions targeting non-IDUs to prevent initiation
of injecting drug use.
•Honest information on modes of administration;
•Information on safer and effective non-IDU modes of administration
27. Reference:
• Jean-Paul Grund, Olga Balakireva, Olena Sakovich, Yuliya
Rubanets, Marina Ryabova, Cas Barendregt, Nataliya Levchuk,
Tatyana Bondar. Initiation into Injecting Drug Use In Ukraine:
Results From a Respondent Driven Sampling Study Among Young
IDUs and Their Non-IDU Peers. Presented at the Seventeenth
International Conference on the Reduction of Drug Related Harm,
Vancouver, Canada, May 3, 2002 (Abs.No. We.07.1).
J-P Grund